BMY
<% (signals.list.current.rate).substr(0,7) %>
<% signal.analyst %>
Last Updated: Jun 17, 2026 03:22:41 PM (GMT)
BMY: The current live price is 55.99, which has changed by +0.27% from the previous price.
Support and Resistance Levels The current support levels are 55.88667, 55.78333, and 55.72667, with resistance levels at 56.04667, 56.10333, and 56.20667. The pivot point is 55.94333.
Indicators Currently, RSI is at 45.82, indicating a neutral condition. ATR is 0.12201, suggesting low volatility. MACD shows a current value of -0.06904 with a signal of -0.06745, implying a bearish trend. Parabolic SAR is at 56.36496, consistently indicating a downward direction.
Market Sentiment With the price below the pivot point (55.94333) and bearish signals, a bearish scenario is likely.
BMY Signals & Technical Analysis
Market Sentiment
Trend Indicators
Oscillators
Moving Averages
Pivot
About (bmy) Bristol-Myers Squibb Company
Company Background
Bristol-Myers Squibb Company, trading under the symbol BMY on the NYSE, is a global biopharmaceutical leader committed to discovering, developing, and delivering innovative medicines that help patients prevail over serious diseases. Founded in 1887 and headquartered in New York City, the company has a rich history that underscores its dedication to scientific excellence and patient care. With a focus on oncology, immunology, cardiovascular disease, and fibrosis, Bristol-Myers Squibb leverages its robust research capabilities and extensive pipeline to address some of the world's most complex health challenges.
Market Position
Bristol-Myers Squibb has solidified its standing as a formidable player in the biopharmaceutical sector, ranking among the top companies in the industry. With a market capitalization consistently exceeding $150 billion, the company has remained competitive through strategic acquisitions and partnerships that enhance its therapeutic offerings. The company’s flagship products, including Opdivo and Eliquis, have established strong market share, driving significant revenue streams. Bristol-Myers Squibb's commitment to innovation is exemplified by its extensive portfolio of late-stage development candidates that are poised to address unmet medical needs across various therapeutic areas.
Key Financial Highlights
In recent years, Bristol-Myers Squibb has demonstrated robust financial performance, characterized by strong revenue growth and an impressive net income margin. The company reported revenues of approximately $47.5 billion in the last fiscal year, reflecting a year-over-year increase driven by solid sales of key products. With a focus on research and development, Bristol-Myers Squibb allocates a significant portion of its budget to innovative therapies, investing over $6 billion in R&D annually. The company maintains a strong balance sheet with significant cash reserves, providing a solid foundation for future growth and expansion opportunities.
Conclusion
Overall, Bristol-Myers Squibb exemplifies a commitment to innovation and excellence in healthcare. With its strong market position, strategic growth initiatives, and ongoing focus on research and development, BMY is well-positioned to continue making a positive impact in the biopharmaceutical arena.
How to Buy or Trade Bristol-Myers Squibb Company Stock (BMY) with AvaTrade
Trading or investing in Bristol-Myers Squibb Company stock through AvaTrade starts with opening a verified trading account. After registration, complete the KYC verification process by submitting your ID and proof of address, then fund your account using a supported payment method such as bank transfer, debit card, or e-wallet. Once your funds reflect, log into the AvaTrade platform or mobile app and search for the ticker symbol BMY, which represents Bristol-Myers Squibb Company. Before placing a trade, review the live Bristol-Myers Squibb Company share price, market trend, spread, leverage options, and recent market news that could impact the stock price.
The next step is deciding whether you want to buy or sell Bristol-Myers Squibb Company stock. Traders expecting the price to rise typically open a Buy position, while traders expecting weakness in the sector may open a Sell position using CFDs. Enter your preferred trade size, then apply risk management tools such as a stop-loss to limit downside exposure and a take-profit order to secure profits automatically. After confirming the trade, monitor key drivers including Bristol-Myers Squibb Company earnings reports, product or service announcements, business segment performance, revenue growth, and overall stock market sentiment. Many traders also use technical indicators such as moving averages, RSI, and support/resistance levels available on the AvaTrade platform to improve timing and trading decisions.
Related Stocks
Sidebar rates
- <% signal.pair %>
<% signals.active.Current.rate.substr(0,7) %>
